Shingles vaccination is likely to be cost effective at age 65 or 70.
Dobson
Roger
R
D000368:Aged; D003362:Cost-Benefit Analysis; D004739:England; D006562:Herpes Zoster / Q000191:economics / Q000517:prevention & control*; D053061:Herpes Zoster Vaccine / Q000191:economics*; D006801:Humans; D014611:Vaccination / Q000191:economics*; D014852:Wales
D053061:Herpes Zoster Vaccine